GF
CEMI

Gabelli Funds’s Chembio diagnostics, Inc. CEMI Stock Holding History

Gabelli Funds’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-75,000
Closed -$273K – 1097
2013
Q3 		$273K Hold
75,000
– – ﹤0.01% 985
2013
Q2 		$375K Buy
+75,000
New +$348K ﹤0.01% 955

Other funds holding CEMI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $984M AUM 72.08% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

Gabelli Funds's CEMI Position: Q4 2013 in Review

Gabelli Funds sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2013, closing a stake of 75,000 shares — an estimated $273K sold.

Gabelli Funds first reported a position in CEMI in Q2 2013 and held it in 2 quarters. The position peaked at $375K in Q2 2013. 17 funds tracked by Wall St. Rank hold CEMI as of Q4 2013.

  • Gabelli Funds reported no remaining Chembio diagnostics, Inc. position as of Q4 2013 after selling out during the quarter.
  • Gabelli Funds sold 75,000 Chembio diagnostics, Inc. shares in Q4 2013, an estimated $273K.
  • Gabelli Funds first reported a position in Chembio diagnostics, Inc. in Q2 2013 and held it in 2 quarters.
  • Gabelli Funds's Chembio diagnostics, Inc. position peaked at $375K in Q2 2013.
  • 17 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2013.

Based on Gabelli Funds's 13F filing for Q4 2013, filed 7 Feb 2014.